Induction Related BK Viremia in Renal Transplant Patients

Completed

Conditions studied: Disease Due to BK Polyomavirus, Transplantation Infection, Disorder Related to Transplantation

In brief

The increase immunosuppression in our transplant population has led to an unacceptable rate of patients at risk for BK virus nephropathy. Reducing induction immunosuppression by switching from Thymoglobulin to Simulect will reduce the incidence of serum positivity for BK by PCR.

Key facts

Study ID

NCT00610961

Run by

University of Florida

People needed

60

Starts

2007-10-01

Expected to finish

2009-11-01

Last updated by the study team

2011-09-27

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• De novo transplant
• Aged 18-75

You may not qualify if…

• Serious medical condition which, in the opinion of the Principal Investigator, might interfere with the subject's ability to successfully complete the protocol.
• Any medical condition which, in the opinion of the Principal Investigator, might compromise the safety of the subject in participating in the protocol

Where it is running

• University of Florida — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.